Accurate Diagnosis of Adenoid Cystic Carcinoma of Esophagus by New Method

Adenoid cystic carcinoma of the esophagus is a rare malignant tumor of the esophagus, which is easily misdiagnosed in clinic. Recently, researchers such as Yang Wulin and Zhao Jiarong of Hefei Institute of Material Sciences, Chinese Academy of Sciences, have developed a new technique, which combines traditional histological morphology with new immunological markers to achieve accurate diagnosis of adenoid cystic carcinoma of the esophagus. It is of great significance for clinical diagnosis and correct design of treatment plan. The results of the study were published in the International Journal of Clinical and Experimental Medicine.
Esophageal cancer is a general term for a class of diseases. In fact, according to the origin of the disease, it can be divided into many types. Tumors may develop in the surface mucosal epithelial cells of the esophagus, loose connective tissue cells in the submucosal layer, and glandular cells. The treatment and prognosis of various esophageal cancers are different, and accurate diagnosis is needed in the early stage. Adenoid cystic carcinoma of the esophagus is a rare malignant tumor of the esophagus. Previously, it was mainly observed on the basis of morphology, and it was easy to be misdiagnosed as other types of esophageal cancer. Recently, Hefei Tumor Hospital of Chinese Academy of Sciences admitted a referral patient who could not identify the pathological type. The researchers of Hefei Institute of Material Sciences of Chinese Academy of Sciences first observed that the pathological tissue of the patient was located in the submucosa with three typical structures: tubular, sieve and solid by "staining method", and then used the glandular epithelial marker. The pathological changes were marked by histological and myoepithelial markers. Immunohistochemical analysis showed that with the aggravation of the disease, the pathological structure of the lesion developed from tubular and sieve to solid, and the epithelial markers changed accordingly, showing characteristic changes, indicating that the development of cancer cells was accompanied by special internal molecular changes. This specificity can provide molecular markers for the accurate diagnosis of adenoid cystic carcinoma.
Looking for chemical products? Let suppliers reach out to you!
2026-07-11
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
An outbreak of Newcastle disease has occurred in Poland
-
Newcastle Disease has hit Moldova
-
Frequent occurrence of chronic respiratory diseases in autumn and winter
-
The world's $24 billion MS market for rare disease
-
Health food should be labeled 'not medicine' when it is published
-
Irregular diet? Be careful of acute biliary and pancreatic diseases
-
Novo Nordisk Faces a Compliance Test
-
BioNTech’s Founders Turn the Page
-
India’s API Trade Balance Turns Positive
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
Recommend Reading
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
Vertex Buys Crinetics for $10 Billion: Rare Disease M&A Is Back
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
Domestic SBR Market Shows Strong Unilateral Increase
-
China's Acetic Acid Market Continues to Rise
-
On March 24, China's titanium dioxide market prices increased
-
Nature Coatings and Chapelton Collaborate to Develop Sustainable Black Barrier Coating
-
Procter & Gamble Raises US Personal Care Prices Due to Tariff Pressure